Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
10
|
pubmed:dateCreated |
1990-11-20
|
pubmed:abstractText |
The synthesis and intravenous analgesic activity of a series of 3-methyl-4-(N-phenyl amido)piperidines, entries 34-79, is described. The methoxyacetamide pharmacophore produced a series of compounds with optimal analgesic potency and short duration of action. cis-42 was 13,036 times more potent than morphine and 29 times more potent than fentanyl; however, the corresponding diastereomer 43 was only 2778 and 6 times more potent, respectively. Compounds 40, 43, 47, and 57 are extremely short acting; all had durations of action of about 2 min, which was about 1/5 of that of fentanyl in the mouse hot-plate test at a dose equivalent to 2 times the ED50 analgesic dose. Among the many compounds that displayed exceptional analgesic activity, duration of action was one of the main factors for choosing a candidate for further pharmacological investigation. At present, cis-1-[2-(4-ethyl-4,5-dihydro-5-oxo-1H-tetrazol-1-yl)ethyl]-3-meth yl-4- [N-in equilibrium 2-fluorophenyl)methoxyacetamido]piperidine hydrochloride (40) (Anaquest, A-3331.HCl, Brifentanil) is in clinical evaluation. Opiate analgesics that possess short duration of action are excellent candidates for short surgical procedures in an outpatient setting where a rapid recovery is required.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Analgesics,
http://linkedlifedata.com/resource/pubmed/chemical/Fentanyl,
http://linkedlifedata.com/resource/pubmed/chemical/Morphine,
http://linkedlifedata.com/resource/pubmed/chemical/Naloxone,
http://linkedlifedata.com/resource/pubmed/chemical/Piperidines,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Opioid,
http://linkedlifedata.com/resource/pubmed/chemical/Tetrazoles
|
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
0022-2623
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
33
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
2876-82
|
pubmed:dateRevised |
2008-11-21
|
pubmed:meshHeading |
pubmed-meshheading:2170652-Analgesics,
pubmed-meshheading:2170652-Animals,
pubmed-meshheading:2170652-Binding, Competitive,
pubmed-meshheading:2170652-Chemistry, Physical,
pubmed-meshheading:2170652-Dose-Response Relationship, Drug,
pubmed-meshheading:2170652-Drug Design,
pubmed-meshheading:2170652-Fentanyl,
pubmed-meshheading:2170652-Mice,
pubmed-meshheading:2170652-Morphine,
pubmed-meshheading:2170652-Naloxone,
pubmed-meshheading:2170652-Physicochemical Phenomena,
pubmed-meshheading:2170652-Piperidines,
pubmed-meshheading:2170652-Rats,
pubmed-meshheading:2170652-Receptors, Opioid,
pubmed-meshheading:2170652-Tetrazoles,
pubmed-meshheading:2170652-Time Factors
|
pubmed:year |
1990
|
pubmed:articleTitle |
Synthesis and pharmacological evaluation of a series of new 3-methyl-1,4-disubstituted-piperidine analgesics.
|
pubmed:affiliation |
Anaquest Pharmaceuticals, BOC Technical Center, Murray Hill, New Jersey 07974.
|
pubmed:publicationType |
Journal Article
|